跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
倍氯米松福莫特罗吸入气雾剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Beclometasone Dipropionate and Formoterol Inhalation Aerosol
Approved
化学药品
Beclometasone Dipropionate and Formoterol Inhalation Aerosol
Chiesi Farmaceutici Spa
🇨🇳 National Medical Products Administration
Approval Date
Dec 16, 2022
Approval ID
1z32T3DIyuY
Company
Chiesi Farmaceutici Spa
Type
化学药品
Approval Details
Approval Id
1z32T3DIyuY
Approval Number
国药准字HJ20181177
Generic Name
倍氯米松福莫特罗吸入气雾剂
Generic Name En
Beclometasone Dipropionate and Formoterol Inhalation Aerosol
Drug Type
化学药品
Dosage Form
吸入气雾剂
Strength
每瓶120揿,每揿含丙酸倍氯米松100μg和富马酸福莫特罗6μg
Reg Date
2022-12-16
Expired Date
2027-12-15
Company Name
Chiesi Farmaceutici Spa
Production Company Name
Chiesi Farmaceutici Spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 16, 2022
Approval ID
1z32T3DIyuY
Type
化学药品
Back to NMPA Approvals